Dyne Therapeutics
DYN
15.97
+0.57
+3.70%
Dyne Therapeutics
US · DYN
#2540 by market cap
Listed 2020
15.97
+0.57
+3.70%
Live - 5344 symbols - heartbeat 142s ago
· 2026-10-08 07:32
Pre-market
16.12
+0.94%
After-hours
16.00
+0.19%
- Market cap
- 2.98B
- P/E (TTM)i
- -4.90
- P/Bi
- 4.25
- EPSi
- -3.47
- Div yieldi
- 0.00%
- 52W posi
- 17%
Reader sentiment
Are you bullish or bearish on DYN?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 14 analysts
Buy
Avg price target
34.67 +117.1%
Price target rangecurrent 15.97
Low10.00
Avg34.67
High50.00
Buy 93%
Hold 0%
Sell 7%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-30 | LifeSci Capital | -- | BUY | 40.00 |
| 2026-09-30 | Stifel | -- | BUY | 37.00 |
| 2026-09-30 | H.C. Wainwright | -- | BUY | 32.00 |
| 2026-09-29 | Piper Sandler | -- | BUY | 47.00 |
| 2026-09-23 | Raymond James | -- | BUY | 37.00 |
| 2026-09-09 | Baird | -- | BUY | 26.00 |
| 2026-09-09 | Morgan Stanley | -- | BUY | 36.00 |
| 2026-09-08 | LifeSci Capital | -- | BUY | 40.00 |
| 2026-09-08 | Jefferies | -- | BUY | 50.00 |
| 2026-09-08 | Stifel | -- | BUY | 37.00 |
| 2026-09-08 | RBC Capital | -- | BUY | 30.00 |
| 2026-09-08 | J.P. Morgan | -- | SELL | 10.00 |
| 2026-08-25 | Raymond James | -- | BUY | 40.00 |
| 2026-08-04 | Raymond James | -- | BUY | 40.00 |
| 2026-07-31 | LifeSci Capital | -- | BUY | 44.00 |
| 2026-07-31 | Morgan Stanley | -- | BUY | 45.00 |
| 2026-07-31 | Stifel | -- | BUY | 37.00 |
| 2026-07-30 | Piper Sandler | -- | BUY | 47.00 |
| 2026-07-30 | J.P. Morgan | -- | HOLD | -- |
| 2026-07-29 | Chardan Capital | -- | BUY | 38.00 |
| 2026-07-29 | LifeSci Capital | -- | BUY | 44.00 |
| 2026-07-29 | RBC Capital | -- | BUY | 35.00 |
| 2026-07-28 | TD Cowen | -- | BUY | -- |
| 2026-07-28 | Morgan Stanley | -- | BUY | 47.00 |
| 2026-07-27 | Evercore | -- | BUY | 33.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 0 upgrades vs 1 downgrade among tracked analyst rating changes.
- Most recent: J.P. Morgan moved from Hold to Sell on 2026-09-08.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-09-08 | J.P. Morgan | HOLD → SELL | 10.00 |
Quote time 2026-10-08 07:32:18 · For reference only, not investment advice and not tailored to your situation.